Testimony on Possible Switch of Orlistat (Xenical) to OTC Status

January 23, 2006

Testimony of Sidney M. Wolfe M.D. and Elizabeth Barbehenn, Ph.D.,
Public Citizen’s Health Research Group

Before the FDA Non-Prescription and Endocrine and Metabolic Drug Advisory Committees
Hearing on Possible Switch of Orlistat (Xenical) to OTC Status

View the presentation slides in pdf format